Insulet, US45784P1012

Insulet announces November results date: what it means for Insulet stock

Published on 10/04/2026 at 18:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Insulet stock costs EUR 116.08 in weekend trading on October 4, 2026 versus EUR 116.08 at Xetra. Results are due November 4.

Aquarell Insulet-Campus Massachusetts – Glasgebäude im Herbstlaub mit Teich und blauem Himmel
Insulet Hauptsitz als Aquarell: New-England-Campus mit Herbstlaub, Glasgebäuden und Teich, US45784P1012 Medizintechnik, Illustration mit AI erstellt.

On October 1, 2026, Insulet Corporation announced that it will report its third-quarter 2026 financial results on November 4, 2026, before the opening of the financial markets, according to FT.com.

At 6:06 p.m. CEST on October 4, 2026, Lang & Schwarz quoted Insulet at EUR 116.08 in weekend trading, unchanged at 0.00 percent versus the EUR 116.08 close at Lang & Schwarz on October 2, 2026.

Weekend trading holds at EUR 116.08

The quoted price was EUR 116.08, with a bid of EUR 115.85 and an ask of EUR 116.30. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Insulet stock.

Results date set for November 4

Insulet Corporation said its third-quarter 2026 results will be released before market opening on November 4, 2026. Management will host a conference call at 8:00 a.m. Eastern Time on the same date, with access details to be provided through the company’s investor-relations website. The announcement identifies the listed issuer as Insulet Corporation and its primary ticker as Nasdaq: PODD. These details were reported in the company announcement carried by FT.com.

Next Xetra session

The next Xetra session is scheduled for October 5, 2026. The company’s results announcement is scheduled for November 4, 2026.

Disclaimer...

en | US45784P1012 | INSULET | boerse | 70226876 | bgmi